COVID-19

NextPlat Announces Completion of Merger and Business Combination with Progressive Care Inc. as Company Focuses on Growth in Healthcare, Technology and Personal Wellness Markets

Progressive Care Stock to Cease Trading Today, October 1, 2024 COCONUT GROVE, Fla., Oct. 1, 2024 /PRNewswire/ -- NextPlat Corp (NASDAQ:…

1 year ago

Black Book IT Leader Survey Reveals 8 Technologies Draining Value From Health Systems

Over 900 healthcare technology experts identified key data systems that fail to deliver ROI and siphon funds from providers after…

1 year ago

Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025

BERKELEY, Calif. and MAINZ, Germany, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),…

1 year ago

Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines

CAMBRIDGE, MA and TAIPEI, TAIWAN / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Cenra Healthcare, the sales…

1 year ago

Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS) ("Biophytis" or the…

1 year ago

COVID’s ‘Hidden Figure’ Addresses ‘Techanthropy’ and Small Business Challenges in New Product and National Column

BALTIMORE, MD / ACCESSWIRE / September 30, 2024 / Tiffany Tate, CEO of VAULT Technologies and a recognized leader in…

1 year ago

NervGen Pharma Provides Update on Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury

Target enrollment in the chronic cohort close to completionVancouver, British Columbia--(Newsfile Corp. - September 30, 2024) - NervGen Pharma Corp.…

1 year ago

Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403

CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first participant in the…

1 year ago